CannRx

CannRx is a specialty pharmaceutical company dedicated to the development of high-quality, pharmaceutical-grade cannabis-based products and advanced delivery technologies. The company leverages its proprietary CannTrap and I-Flow platforms to improve the solubility, bioavailability, and controlled delivery of cannabinoids. Its clinical pipeline includes programs for chronic pain, sleep disorders, and neurodegenerative conditions like Parkinson's disease. CannRx was acquired by One World Products to integrate its scientific expertise and intellectual property into a broader global cannabis supply chain. The company aims to bridge the gap between traditional herbal cannabis and pharmaceutical-grade medicine through rigorous clinical validation.